Financial Performance - The company's revenue for Q1 2022 was CNY 419,024,555.20, representing a 14.84% increase compared to CNY 364,865,914.40 in the same period last year[3] - Net profit attributable to shareholders was CNY 23,934,028.38, a 30.72% increase from CNY 18,309,536.86 year-over-year[3] - The total operating revenue for Q1 2022 was CNY 419,024,555.20, an increase of 14.8% compared to CNY 364,865,914.40 in the same period last year[17] - The total profit for Q1 2022 reached CNY 28,083,118.93, up from CNY 21,847,623.91 in the same period last year, reflecting a growth of 28.5%[19] - Operating profit for Q1 2022 was CNY 28,052,816.32, compared to CNY 21,962,155.08 in Q1 2021, indicating an increase of 27.5%[19] - The net profit for Q1 2022 was CNY 23,934,028.38, an increase of 30.5% compared to CNY 18,309,536.86 in Q1 2021[19] - The total comprehensive income for Q1 2022 was CNY 23,910,742.98, an increase from CNY 18,421,173.88 in Q1 2021[20] - The basic and diluted earnings per share remained stable at CNY 0.22 for both Q1 2022 and Q1 2021[20] Cash Flow and Liquidity - The net cash flow from operating activities was negative CNY 77,047,987.38, a decline of 129.95% compared to negative CNY 33,507,032.37 in the previous year[8] - The cash flow from operating activities showed a net outflow of CNY 77,047,987.38, worsening from a net outflow of CNY 33,507,032.37 in the previous year[23] - The company reported cash inflows from operating activities of CNY 250,461,187.75, compared to CNY 220,316,195.05 in the previous year[21] - Cash and cash equivalents at the end of Q1 2022 totaled CNY 393,182,892.99, down from CNY 639,413,763.66 at the end of Q1 2021[24] - The company's cash and cash equivalents as of March 31, 2022, were CNY 629,669,893.05, compared to CNY 575,933,319.95 at the end of Q1 2021, indicating a growth of 9.3%[14] Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,309,002,177.43, up 2.75% from CNY 3,220,519,913.33 at the end of the previous year[3] - The total assets of the company as of March 31, 2022, were CNY 3,309,002,177.43, compared to CNY 3,220,519,913.33 at the same time last year, reflecting a growth of 2.8%[15] - The total liabilities increased to CNY 1,658,170,350.13 from CNY 1,593,652,077.90, which is an increase of 4.1%[15] Shareholder Information - The company had a total of 19,688 common shareholders at the end of the reporting period[10] Research and Development - Research and development expenses increased by 37.47% to CNY 16,600,512.51 from CNY 12,075,347.94 in the same period last year[8] - Research and development expenses for Q1 2022 were CNY 16,600,512.51, up from CNY 12,075,347.94, representing an increase of 37.1% year-over-year[17] Other Financial Metrics - The weighted average return on equity was 1.46%, slightly up from 1.44% in the previous year[3] - The company incurred a credit impairment loss of CNY -922,995.92 in Q1 2022, compared to CNY -68,494.03 in Q1 2021[19] - The company received government subsidies amounting to CNY 341,733.16, which was a decrease of 59.33% compared to the previous year[8] - The gross profit for Q1 2022 was CNY 28,510,407.65, reflecting a gross margin of approximately 6.8%[17] - The total operating costs for Q1 2022 amounted to CNY 390,514,147.55, up 14% from CNY 342,942,507.96 in Q1 2021[17] - Accounts receivable increased to CNY 295,353,946.87 from CNY 224,555,559.59, representing a rise of 31.5% year-over-year[14] - The company reported a significant increase in accounts receivable, which rose by 31.53% to CNY 295,353,946.87 from CNY 224,555,559.59[7] - Inventory levels rose to CNY 445,771,293.08, up from CNY 410,485,068.93, marking an increase of 8.6%[14] - Short-term borrowings increased by 98.74% to CNY 459,273,751.29, reflecting a higher demand for working capital[7] - The cash outflow from investing activities was CNY 77,905,467.91, significantly higher than CNY 21,974,442.25 in the previous year[23]

Financial Performance - The company's operating revenue for 2021 was ¥1,625,072,614.01, representing a 3.63% increase compared to ¥1,568,185,277.06 in 2020[19]. - The net profit attributable to shareholders for 2021 was ¥98,594,923.92, a decrease of 4.76% from ¥103,525,728.78 in 2020[19]. - The basic earnings per share for 2021 was ¥0.96, down 23.81% from ¥1.26 in 2020[19]. - The company's total revenue for 2021 was CNY 1,530,147,420.14, representing a year-on-year increase of 4.29%[63]. - The agricultural sector contributed ¥1,530,147,420.14, accounting for 94.16% of total revenue, with a growth of 4.29% year-on-year[60]. - The company achieved export revenue of CNY 471.76 million, accounting for 29.03% of total revenue[48]. - The company reported a total revenue of 1.5 billion RMB for the fiscal year 2021, representing a year-over-year growth of 12%[131]. - The company reported a significant increase in revenue, achieving a total of 1.5 billion RMB for the year, representing a growth of 20% compared to the previous year[199]. Dividend and Share Capital - The company plans to distribute a cash dividend of 2.00 CNY per 10 shares (including tax) based on a total of 109,600,000 shares, with no bonus shares issued[4]. - A cash dividend of ¥2.00 per 10 shares (before tax) will be distributed, totaling ¥21,920,000.00, which accounts for 100% of the profit distribution[150][151]. - The company will also increase its share capital by 3 shares for every 10 shares held, resulting in a total capital increase of 32,880,000 shares, raising the total share capital to 142,480,000 shares[151]. Market and Industry Trends - The global pesticide market is projected to grow at a compound annual growth rate (CAGR) of 2.3% over the next five years, driven by population growth and increased food demand[30]. - The domestic pesticide market size is expected to reach ¥541 billion by 2025, with a CAGR of 3.6% from 2020[30]. - The pesticide industry is increasingly recognized for its role in ensuring effective supply of important agricultural products and promoting green development during the 14th Five-Year Plan period[32]. - The company reported a significant increase in the market concentration of the pesticide industry, with leading companies capturing a larger market share[29]. Research and Development - The company has established a complete pesticide production and R&D system, with 46 invention patents obtained by the end of the reporting period[34]. - The company has a strong focus on independent research and development, with several patented technologies enhancing production efficiency and reducing costs[43]. - The company has successfully developed proprietary pesticide products, including "Fluopyram" and "Trifloxystrobin," with patents granted in multiple countries[34]. - The company is investing 200 million RMB in R&D for new technologies in bio-agriculture over the next two years[131]. - Research and development expenses increased by 20% in 2021, totaling 100 million RMB, to support new technology initiatives[134]. Operational Efficiency - The company has maintained its main business operations without any changes since its listing[18]. - The company’s integrated production chain includes intermediates, active ingredients, and formulations, providing safe, environmentally friendly, and efficient pesticide products[34]. - The company has implemented a comprehensive salary management system that includes basic salary, position salary, and performance bonuses to attract and retain talent[147][148]. - The company has increased safety investment and enhanced safety measures, including the implementation of HAZOP analysis to identify safety hazards in production processes[183]. Environmental Commitment - The company has increased its environmental protection investment in recent years, ensuring that current emissions meet national standards, and will further promote emission reduction[101]. - The company has implemented measures to ensure compliance with environmental regulations and standards[165]. - The company was recognized as a "Water-Saving Enterprise" in Shandong Province, reflecting its commitment to resource recycling and efficiency[172]. - The company has adopted a clean production approach, using natural gas as fuel to minimize air pollution and environmental impact[172]. Risk Management - The company emphasizes the importance of risk awareness regarding forward-looking statements in the report, indicating potential operational risks in future developments[4]. - The company recognizes market competition risks and plans to address these through continuous innovation and improvement in production processes[100]. - The company faces risks from price fluctuations of its main products, which include pesticide raw materials and intermediates, due to market competition and environmental policies[102]. - The company is committed to risk mitigation during project implementation, ensuring timely completion and production contributions[103]. Corporate Governance - The company adheres to strict governance practices, ensuring compliance with relevant laws and regulations, and maintaining transparency in information disclosure[109]. - The company has established a well-defined corporate governance structure, including a board of directors and supervisory board, ensuring independent operation[112]. - The company has implemented a registration system for insider information to enhance transparency[139]. - The company has actively participated in governance and decision-making, ensuring the protection of minority shareholders' rights[142]. Strategic Initiatives - The company plans to enhance its market share by strengthening its marketing system and expanding both domestic and international markets in 2022[99]. - The company aims to complete the construction of several projects, including the bromopropyl raw material project and the formulation project, to optimize product layout and enhance profitability[99]. - The company is exploring potential acquisitions to enhance its product portfolio, with a budget of 500 million RMB allocated for this purpose[131]. - The company is focused on maintaining a sustainable growth trajectory while navigating market challenges and opportunities[118].

证券代码：003042 证券简称：中农联合 公告编号：2021-040 山东中农联合生物科技股份有限公司 关于参加山东辖区上市公司 2021 年度 投资者网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 为进一步增强与广大投资者的互动交流，切实提高公司透明度、规范运作和 治理水平，山东中农联合生物科技股份有限公司（以下简称"公司"）将参加由 山东监管局、山东上市公司协会联合举办的"山东辖区上市公司 2021 年度投资 者网上集体接待日活动"，现将有关事项公告如下： 本次活动将通过深圳市全景网络有限公司提供的互联网平台举行，投资者可 登录"全景•路演天下"网站（http://rs.p5w.net）参与本次活动，互动交流时间为 2021 年 11 月 16 日（星期二）14:00-16:00。 届时公司董事会秘书颜世进先生及证券事务代表徐伟勋先生将通过网络在 线形式与投资者进行交流沟通，欢迎广大投资者积极参与。 特此公告。 山东中农联合生物科技股份有限公司 董事会 2021 年 11 月 13 日 ...

Financial Performance - The company's revenue for Q3 2021 reached ¥369,242,131.99, representing a 21.00% increase compared to the same period last year[2] - Net profit attributable to shareholders was ¥23,951,925.77, a significant increase of 402.19% year-on-year[2] - The basic earnings per share (EPS) for the period was ¥0.22, reflecting a 266.67% increase compared to the previous year[2] - The company's total revenue for Q3 2021 was 49,172,749.15, a decrease of 48.54% compared to the previous period due to a decline in product sales gross margin[7] - Net profit for Q3 2021 was 46,327,317.22, representing a 42.91% decrease from the previous year, primarily due to the decline in total profit[7] - The company's net profit for the third quarter of 2021 was CNY 46,327,317.22, down from CNY 81,144,297.59 in the same quarter of 2020, reflecting a decrease of approximately 42.8%[19] - The total comprehensive income for Q3 2021 was CNY 46,374,868.87, down from CNY 81,211,045.95 year-over-year[20] - Basic and diluted earnings per share for Q3 2021 were CNY 0.46, compared to CNY 0.99 in Q3 2020, reflecting a decline of 53.5%[20] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥3,009,318,933.62, marking a 30.81% increase from the end of the previous year[2] - The company's total liabilities as of September 30, 2021, were CNY 1,434,195,403.71, up from CNY 1,304,297,929.35 at the end of 2020, indicating an increase of about 9.93%[17] - Total assets reached CNY 3,009,318,933.62 as of September 30, 2021, compared to CNY 2,300,481,298.05 at the end of 2020, marking an increase of approximately 30.8%[17] - Total liabilities reached CNY 1,304,297,929.35, with current liabilities at CNY 1,132,371,147.38 and non-current liabilities at CNY 171,926,781.97[27] - Owner's equity totaled CNY 996,183,368.70, with retained earnings of CNY 536,111,965.95[28] Cash Flow - Cash flow from operating activities showed a negative net amount of ¥-86,760,326.50, indicating a decline of 148.90% year-to-date[2] - Operating cash inflow increased by 31.93% to 814,111,711.36, attributed to a higher cash collection ratio from sales[7] - Cash inflow from operating activities was CNY 814,111,711.36, an increase of 32% from CNY 617,074,366.44 in the previous year[22] - Cash outflow from operating activities totaled CNY 900,872,037.86, up from CNY 651,931,900.33, resulting in a net cash flow from operating activities of CNY -86,760,326.50[22] - Cash inflow from investment activities was CNY 410,070,260.00, significantly higher than CNY 24,859,288.00 in the previous year[23] - Cash outflow from investment activities reached CNY 801,484,500.46, compared to CNY 122,018,809.00 in the same period last year, leading to a net cash flow from investment activities of CNY -391,414,240.46[23] - Cash inflow from financing activities was CNY 1,049,698,181.25, a substantial increase from CNY 431,799,691.65 in the previous year[23] - The net increase in cash and cash equivalents for the period was CNY 47,046,943.78, compared to CNY 22,958,718.82 in the same period last year[23] - The ending balance of cash and cash equivalents was CNY 240,498,339.10, up from CNY 140,668,257.78 at the end of the previous year[23] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 17,395[9] - The largest shareholder, China Agricultural Production Materials Group, holds 30.57% of the shares, totaling 33,500,000 shares[10] - The shareholder voting rights delegation agreement signed on August 31, 2021, increased the voting rights held by China Agricultural Production Materials Group from 6.73% to 9.20%[12] - The company issued new shares, resulting in a 33.33% increase in share capital to 109,600,000.00[7] - Capital reserves increased by 152.17% to 841,742,975.63, driven by the premium from the initial public offering[7] Operational Highlights - The company has made progress on its project to produce 3,300 tons of pesticide raw materials, with trial production starting in July 2021[12] - The company is in the process of expanding its market presence and developing new products, as indicated by the ongoing construction of the bromopropyl project[12] - The company reported a decrease in research and development expenses to CNY 41,763,144.09 in Q3 2021 from CNY 47,165,463.43 in Q3 2020, a reduction of approximately 11.5%[19] Financial Adjustments - The adjustment for the new leasing standard resulted in a reduction of retained earnings by CNY 359,701.72[28] - The company recognized a right-of-use asset of CNY 3,324,022.46 and a corresponding lease liability of CNY 3,247,426.97 due to the new leasing standard[28] - The company reported a significant reduction in asset impairment losses by 80.86%, amounting to -1,848,304.40, due to rising product sales prices[7] - Financial expenses decreased by 41.36% to 14,000,590.41, due to reduced exchange losses and increased interest income[7] Audit Information - The company has not undergone an audit for the third-quarter report[29]

Financial Performance - The company reported a total revenue of 1.2 billion RMB for the first half of 2021, representing a year-on-year increase of 15%[16]. - The company's operating revenue for the first half of 2021 was ¥811,054,448.27, a decrease of 6.17% compared to the same period last year[21]. - The net profit attributable to shareholders was ¥22,375,391.45, representing a significant decline of 70.70% year-on-year[21]. - The net profit after deducting non-recurring gains and losses was ¥19,834,140.41, down 73.70% from the previous year[21]. - The total profit for the first half of 2021 was CNY 25,163,494.71, down from CNY 89,836,696.81 in the previous year, indicating a decrease of about 72%[162]. - The company's net profit margin for the first half of 2021 was approximately 2.83%, compared to 10.88% in the first half of 2020[160]. - The company reported a significant loss of 12,530,12 CNY in operating profit from its subsidiary engaged in chemical product production[71]. Revenue Breakdown - The revenue from the pesticide industry accounted for 91.86% of total revenue, amounting to ¥745,056,556.16, down 7.17% from ¥802,575,541.49[52]. - The company's revenue in the pesticide industry was approximately ¥745.06 million, representing a year-over-year decrease of 7.17%[54]. - Domestic sales decreased by 12.28% to ¥576,239,537.92, while international sales increased by 13.18% to ¥234,814,910.35[53]. Cost and Profitability - The gross profit margin improved to 35%, up from 30% in the same period last year, indicating better cost management and pricing strategies[16]. - The company's gross profit margin decreased significantly, leading to a total profit of ¥25,163,494.71, a decline of 71.99% from ¥89,836,696.81 in the previous year[50]. - The company's operating costs increased by 2.67% despite a decrease in revenue, primarily due to a significant rise in raw material prices[34]. Research and Development - Research and development expenses increased by 25% to 100 million RMB, focusing on innovative pesticide formulations and sustainable agricultural practices[16]. - The company applied for 5 domestic invention patents and 4 PCT patents in the first half of 2021, with significant international patent applications in 15 countries[36]. - Research and development expenses were reduced by 18.83% to ¥27,277,499.13 from ¥33,603,863.63[50]. Market Expansion and Strategy - The company plans to launch two new pesticide products in Q4 2021, aiming to capture a larger market share in the agricultural sector[16]. - The company is expanding its market presence in Southeast Asia, with plans to establish distribution channels in three new countries by the end of 2021[16]. - The company focuses on expanding both domestic and international markets, enhancing customer service, and developing new products to improve competitiveness[35]. Environmental and Safety Initiatives - The company emphasizes safety and environmental protection, with advanced waste treatment facilities and recognition as a key chemical enterprise by the Shandong provincial government[41]. - The company has implemented pollution prevention measures and invested in environmental protection facilities, ensuring that major pollutants meet discharge standards and are reduced effectively[86]. - The company has established an online monitoring system for wastewater discharge, with real-time data uploads and monthly third-party testing to ensure compliance with environmental standards[91]. Financial Health and Investments - The company achieved a net cash inflow from financing activities of ¥489,778,171.62, an increase of 345.49% compared to ¥109,941,080.32 in the previous year[50]. - The company reported a total asset value of ¥2.9 billion at the end of the reporting period, with cash and cash equivalents amounting to ¥413.18 million, representing 14.25% of total assets[60]. - The company invested approximately ¥150.06 million during the reporting period, a 166.66% increase compared to the previous year[63]. Legal and Compliance Matters - The company reported a total of 212.94 million yuan in a lawsuit against Jiangsu Huangma Agricultural Chemical Co., which has not been successfully executed, resulting in a provision for bad debts[105]. - There are no significant litigation or arbitration matters reported during the reporting period[108]. - The company has not faced any administrative penalties for environmental issues during the reporting period, indicating compliance with environmental laws and regulations[91]. Shareholder and Equity Information - The company raised a total of CNY 590.74 million by issuing 27.4 million shares at a price of CNY 21.56 per share during its IPO[136]. - The total number of shares increased from 82.2 million to 109.6 million after the issuance, resulting in a dilution of earnings per share[136]. - The company has a total of 38 million yuan in approved guarantees during the reporting period, with an actual guarantee amount of 11.9 million yuan, which accounts for 7.66% of the company's net assets[127].

Financial Performance - The company's operating revenue for Q1 2021 was ¥364,865,914.40, representing a 4.59% increase compared to ¥348,839,814.92 in the same period last year[8] - The net profit attributable to shareholders for Q1 2021 was ¥18,309,536.86, a decrease of 2.57% from ¥18,792,758.89 in the previous year[8] - The basic earnings per share for Q1 2021 was ¥0.22, down 4.35% from ¥0.23 in the same period last year[8] - The total profit for the period was CNY 21,847,623.91, slightly up from CNY 21,600,872.29 in the previous year[39] - The company's total comprehensive income for Q1 2021 was CNY 18,421,173.88, down from CNY 18,792,758.89 in the same period last year[40] Cash Flow and Liquidity - The net cash flow from operating activities improved by 24.40%, reaching -¥33,507,032.37, compared to -¥44,324,144.44 in the same period last year[8] - The company reported a net cash inflow from financing activities of ¥501,086,969.27, a significant increase of 1011.14% due to the public offering of shares[15] - The cash inflow from operating activities was CNY 220,316,195.05, compared to CNY 225,264,975.08 in the previous period, indicating a decrease of about 2.2%[46] - The cash and cash equivalents increased significantly to CNY 764,763,306.72 from CNY 223,134,546.24[32] - The company experienced a net increase in cash and cash equivalents of 445,962,368.34 CNY, contrasting with a decrease of -66,620,971.71 CNY in the previous period[48] Assets and Liabilities - Total assets at the end of the reporting period increased by 28.31% to ¥2,951,821,023.72 from ¥2,300,481,298.05 at the end of the previous year[8] - The total liabilities increased to CNY 1,400,536,830.45 from CNY 1,304,297,929.35[32] - Long-term borrowings increased to CNY 265,343,473.91 from CNY 166,021,066.79[32] - The company's contract liabilities decreased by 40.91% to ¥71,837,046.10, reflecting the gradual execution of performance obligations[15] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 60,772[11] - The largest shareholder, China Agricultural Production Materials Group, held 30.57% of the shares, amounting to 33,500,000 shares[11] - The net assets attributable to shareholders rose by 55.72% to ¥1,551,284,193.27 from ¥996,183,368.70 at the end of the previous year[8] Investment and Development - The construction in progress for the annual production of 3,300 tons of pesticide project saw an investment increase of 38.23%, totaling ¥223,006,544.52[15] - The company plans to expand its market presence and invest in new product development to drive future growth[38] - Research and development expenses were CNY 12,075,347.94, slightly down from CNY 12,087,648.59 in the previous period[38] - The company's research and development expenses for Q1 2021 were CNY 5,432,922.89, slightly higher than CNY 5,133,823.25 in the previous year[42] Operational Efficiency - The company's cash flow from investment activities showed a net outflow of -1,653,908.80 CNY, compared to a net inflow of 4,647,766.00 CNY in the previous period, indicating a shift in investment strategy[51] - The company reported a credit impairment loss of CNY 385,515.97, a significant improvement from a loss of CNY 4,316,682.01 in the previous period[43] - The operating profit for the period was CNY 21,962,155.08, an increase from CNY 21,169,775.13 in the previous year[39]

Financial Performance - The company reported a total revenue of 1.2 billion RMB for the year 2020, representing a year-on-year increase of 15%[13] - The net profit attributable to shareholders was 150 million RMB, an increase of 20% compared to the previous year[13] - The company's operating revenue for 2020 was ¥1,568,185,277.06, representing a 14.74% increase compared to ¥1,366,782,415.61 in 2019[18] - The net profit attributable to shareholders for 2020 was ¥103,525,728.78, a decrease of 29.64% from ¥147,136,392.02 in 2019[18] - The net cash flow from operating activities increased by 19.23% to ¥114,723,315.42 in 2020, compared to ¥96,221,623.43 in 2019[18] - The total assets at the end of 2020 were ¥2,300,481,298.05, reflecting a 21.94% increase from ¥1,886,542,480.81 at the end of 2019[18] - The basic earnings per share for 2020 were ¥1.26, a decrease of 29.61% from ¥1.79 in 2019[18] - The weighted average return on equity for 2020 was 10.73%, down 6.43% from 17.16% in 2019[18] - The company reported a total pesticide export volume of 239.5 million tons in 2020, a year-on-year increase of 29.3%[28] - The company achieved a total revenue of 1,568.19 million yuan in 2020, an increase of 14.74% compared to the previous year[50] Market Expansion and Strategy - User data showed a growth in customer base by 25%, reaching 500,000 active users by the end of 2020[13] - The company plans to expand its market presence in Southeast Asia, targeting a 30% increase in market share within the next two years[13] - The company is actively expanding its domestic market presence, particularly in the small packaging segment, leading to increased market share[51] - The company plans to enhance its product line and expand into international markets, focusing on new product development and improving production processes[91] - The company aims to increase its market share by establishing long-term strategic partnerships with international agrochemical companies[92] Research and Development - The company has allocated 200 million RMB for research and development in new agricultural technologies for the upcoming fiscal year[13] - New product development includes the launch of three innovative pesticide formulations, expected to contribute an additional 100 million RMB in revenue in 2021[13] - The company has obtained 39 invention patents and developed the pesticide product "Fluopyram" with independent intellectual property rights, which has been successfully launched in the market[34] - The company emphasizes independent research and development, leveraging its existing R&D team to enhance product quality and reduce costs[52] - The number of R&D personnel increased by 7.84% to 165, representing 9.70% of total employees[71] Operational Efficiency - A strategic acquisition of a local competitor is anticipated to enhance production capacity by 40% and reduce operational costs by 15%[13] - The production capacity for pesticide raw materials is 7,800 tons per year, with a utilization rate of 112.50%[54] - The company has successfully scaled up the production of key intermediates for the production of Imidacloprid, Acetamiprid, and Thiamethoxam, meeting market demand[44] - The company has established a complete pesticide R&D, production, and sales system, focusing on safety, environmental protection, and quality management[34] Financial Management and Dividend Policy - The board has decided not to distribute cash dividends for the year, opting to reinvest profits into business expansion[5] - The company has committed to a cash dividend policy, with an expected payout of 200 million RMB for the upcoming fiscal year[141] - The company has established a dividend policy for 2021-2023, aiming to clarify standards and ratios for future distributions[102] Risk Management - The company faces potential risks including market competition and fluctuations in raw material prices, which could impact future performance[5] - The company has identified risks related to investment projects not meeting expected returns due to potential adverse changes in regulatory policies and market conditions[98] - The company is facing market competition risks due to the increasing number of mergers in the agrochemical industry and the rising technical capabilities of domestic competitors[93] Environmental Compliance and Safety - The company emphasizes environmental protection and has invested in improving its waste management systems to comply with national standards[95] - A comprehensive safety management system has been established, including various safety production responsibility and training regulations[171] - The company is classified as a key pollutant discharge unit, actively managing emissions and adhering to pollution discharge standards[178] - The company reported a total emission of 1.293 tons of COD, with a concentration of 23.2 mg/l, indicating compliance with regional water pollution standards[179] Shareholder and Governance - The company reported a total of 82,200,000 shares, with 100% being limited shares held by domestic investors[189] - The largest shareholder, Zhongnong Shanghai, holds 40.75% of the shares, while Xu Hui holds 12.77%[193] - The company has not conducted any repurchase transactions among the top 10 shareholders during the reporting period[194] - The company emphasizes compliance with laws and regulations, ensuring fair treatment of all shareholders and maintaining transparency in information disclosure[169]